Immunosuppression versus Supportive Care on Kidney Outcomes in IgA Nephropathy in the Real-World Setting
暂无分享,去创建一个
Mengchun Gong | F. Hou | Chunbo Chen | Gang Xu | Q. Wan | Guisen Li | Cheng Wang | Y. Zha | Yi-lun Zhou | S. Nie | J. Weng | L. Su | Yanqin Li | Ruixuan Chen | Yue Cao | Xin Xu | G. Su | Qiongqiong Yang | Bicheng Liu | Y. Kong | Ying Hu | Shiyu Zhou | Qiqing Gao | Huafeng Liu | Ying-qian Tang | Yongjun Shi | Hao Zhao | Hua Li | Hong-yan Xu | A. Guo | Yang Li | Jing Sun
[1] R. Lafayette,et al. Considering the Treatment of IgA Nephropathy. , 2023, American Society of Nephrology. Clinical Journal.
[2] F. Hou,et al. Effectiveness of Mycophenolate Mofetil Among Patients With Progressive IgA Nephropathy: A Randomized Clinical Trial. , 2023, JAMA network open.
[3] B. Rovin,et al. Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy. , 2022, Kidney international.
[4] David W. Johnson,et al. Effect of Oral Methylprednisolone on Decline in Kidney Function or Kidney Failure in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial. , 2022, JAMA.
[5] E. Zabor,et al. Analysis of composite endpoints with component‐wise censoring in the presence of differential visit schedules , 2022, Statistics in medicine.
[6] B. Rovin,et al. KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases , 2021, KIDNEYS.
[7] C. Wanner,et al. After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy. , 2020, Kidney international.
[8] S. Suissa. Lower Risk of Death With SGLT2 Inhibitors in Observational Studies: Real or Bias? , 2017, Diabetes Care.
[9] Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2017;7:1–59 , 2017, Kidney international supplements.
[10] C. Fitzner,et al. Effects of Two Immunosuppressive Treatment Protocols for IgA Nephropathy. , 2017, Journal of the American Society of Nephrology : JASN.
[11] David W. Johnson,et al. Effect of Oral Methylprednisolone on Clinical Outcomes in Patients With IgA Nephropathy: The TESTING Randomized Clinical Trial , 2017, JAMA.
[12] A. Cambier,et al. Intensive Supportive Care plus Immunosuppression in IgA Nephropathy. , 2016, The New England journal of medicine.
[13] V. D’Agati,et al. New developments in the genetics, pathogenesis, and therapy of IgA nephropathy , 2015, Kidney international.
[14] B. Julian,et al. IgA nephropathy: molecular mechanisms of the disease. , 2013, Annual review of pathology.
[15] Charles A Herzog. Kidney disease in cardiology. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[16] Yusuke Suzuki,et al. Aberrantly glycosylated IgA1 in IgA nephropathy patients is recognized by IgG antibodies with restricted heterogeneity. , 2009, The Journal of clinical investigation.
[17] C. Schmid,et al. A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.
[18] J. Scholey,et al. Remission of proteinuria improves prognosis in IgA nephropathy. , 2007, Journal of the American Society of Nephrology : JASN.
[19] B. Julian,et al. Patients with IgA nephropathy have increased serum galactose-deficient IgA1 levels. , 2007, Kidney international.
[20] S. Tang,et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. , 2005, Kidney international.
[21] F. Locatelli,et al. Corticosteroids in IgA nephropathy: a randomised controlled trial , 1999, The Lancet.
[22] J. Stockman,et al. A New Equation to Estimate Glomerular Filtration Rate , 2011 .
[23] Ajay K. Singh,et al. Combination therapy of prednisone and ACE inhibitor versus ACE-inhibitor therapy alone in patients with IgA nephropathy: a randomized controlled trial. , 2009, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[24] P. Zucchelli,et al. [IgA nephropathy]. , 1985, Medicina clinica.
[25] Tao Jiang,et al. Dovepress Open Access to Scientific and Medical Research Open Access Full Text Article Noninvasively Characterizing the Different Αvβ3 Expression Patterns in Lung Cancers with Rgd-uspio Using a Clinical 3.0t Mr Scanner , 2022 .